ZAI's founder and CEO is Dr. Samantha Du, previously founder and CEO of Hutchison MediPharma, who led healthcare investments at Sequoia Capital in China prior to launching ZAI Lab earlier this year. Live webcasts of the conferences will be available under "Events & Presentations" in the "Investors Relations" section of Zai Lab's website.
Products. ZAI Laboratory, Inc., an innovative drug startup based in Shanghai, has raised more than $30 million from an international group of healthcare investors including Qiming, KPCB and Sequoia. Zai Lab’s experienced team has secured partnerships with leading global biopharma companies, generating a broad pipeline of innovative drug candidates targeting the fast-growing segments of China's pharmaceutical market and addressing unmet medical needs.
Presenter: Dr. Samantha Du, Founder, Chairperson & Chief Executive Officer This category only includes cookies that ensures basic functionalities and security features of the website. SHANGHAI, China and SAN FRANCISCO, June 03, 2019 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, today announced the appointment of Valeria Fantin, Ph.D. as Chief Scientific Officer.
Zai Lab Billy Cho, CFO +86 137 6151 2501 billy.cho@zailaboratory.com. More and more Americans don’t want Trump fully reopening schools yet Is the ‘Umbrella Corporation’ Logo Oddly Similar to a Wuhan Biotech Lab’s?
Necessary cookies are absolutely essential for the website to function properly. We also use third-party cookies that help us analyze and understand how you use this website. Glassdoor gives you an inside look at what it's like to work at Zai Lab, including salaries, reviews, office photos, and more. New Jersey court rules defendant must share phone passcodes with authorities, decision could impact the future of privacy Some concern arose over apparent connections between the video game "Resident Evil" and a … We now have total control. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. The Company is focused on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including in the fields of oncology, autoimmune and infectious diseases. ZAI's founder and CEO is Dr. Samantha Du, previously founder and CEO of Hutchison MediPharma, who led healthcare investments at Sequoia Capital in China prior to launching ZAI Lab earlier this year. Accessible and easy to work from.
https://ml.globenewswire.com/media/918e6105-bc26-48b0-a64b-4f7c05f1ccab/small/zai-lab-logo-png.png
I can spy on and whisper to their conversations with our clients. “We are advancing our internal discovery pipeline with a goal to announce one to two INDs per year starting in 2020. Fantin is a proven leader with over two decades of industry experience in exploratory biology and oncology drug discovery and development.
Dr. … I love the support – It shows that there’s always someone who can assist us rapidly. Log in to see them here or sign up to get started.Create a list of the investments you want to track.Visit a quote page and your recently viewed tickers will be displayed here.Week In Review: BioKangtai Acquires China Rights To AstraZeneca's COVID-19 VaccineZai Lab nabs accelerated review in China for ripretinib applicationWeek In Review: Ocumension Climbs To $2.5 Billion Market Cap After $184 Million Hong Kong IPOTurning Point Therapeutics inks deal with Zai Lab for lead drugTracking Ron Baron's BAMCO Portfolio - Q1 2020 UpdateSmall Caps Build Steam And Biotechs Remain Well-PositionedWeek In Review: CanSino Publishes Positive Data From Trial Of COVID-19 VaccineZai lab doses first Chinese patient in late-stage sulbactam-durlobactam trialWeek In Review: Sorrento Announces mAb Inhibits 100% of SARS-CoV-2 Infection We control the performance and activity of the agents. I can log a query and their response times are amazing. It is mandatory to procure user consent prior to running these cookies on your website.This website uses cookies to improve your experience while you navigate through the website. Zailab has changed the way askOsca performs what was already premium outbound and inbound sales and customer service. You also have the option to opt-out of these cookies. Zailab has changed our business. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies.
“My experience as a cancer researcher and drug discovery leader provides me the opportunity to make an immediate impact towards executing Zai Lab’s vision of building a proprietary pipeline of innovative drugs.”Dr.
Zai lab doses first Chinese patient in late-stage sulbactam-durlobactam trial May. ZLAB | A complete ZLAB overview by MarketWatch.
Company profile.
We now have total control. ASCO 2020 Conference Call: MGD013 & MGC018 May 29, 2020 Developing Breakthrough Biologics, Life-changing Medicines Media: Nancie Steinberg / Robert Flamm ... Zai Lab logo .png.
The Company is focused on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including in the fields of … Her earlier work as a researcher at Merck Research Laboratories focused on epigenetics and kinase drug discovery projects, where she contributed to the development of the first in class HDAC inhibitor vorinostat (ZOLINZA®).Dr. ZAI Laboratory, Inc., an innovative drug startup based in Shanghai, has raised more than $30 million from an international group of healthcare investors including Qiming, KPCB and Sequoia.